319 related articles for article (PubMed ID: 8306335)
1. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
Green D; Bensely D; Schein P
Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
[TBL] [Abstract][Full Text] [Related]
2. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721.
Wasserman TH; Phillips TL; Ross G; Kane LJ
Cancer Clin Trials; 1981; 4(1):3-6. PubMed ID: 6260393
[TBL] [Abstract][Full Text] [Related]
3. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
Schein PS; Green D; Dean SW; McPherson E
Cancer Res; 1987 Feb; 47(3):696-9. PubMed ID: 3802075
[TBL] [Abstract][Full Text] [Related]
4. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
Milas L; McBride WH; Hunter N; Ito H
Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
Cantrell JE; Green D; Schein PS
Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
[TBL] [Abstract][Full Text] [Related]
6. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
[TBL] [Abstract][Full Text] [Related]
7. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
[TBL] [Abstract][Full Text] [Related]
8. The potential of amifostine: from cytoprotectant to therapeutic agent.
Santini V; Giles FJ
Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
[TBL] [Abstract][Full Text] [Related]
9. Chromosome protection by WR-2721 and MPG-single and combination treatments.
Thomas B; Devi PU
Strahlenther Onkol; 1987 Dec; 163(12):807-10. PubMed ID: 2827332
[TBL] [Abstract][Full Text] [Related]
10. WR-2721 as cytotoxic and radioprotective agent in treatment of murine lymphoma with total body irradiation.
Coia LR; Brown DQ; Hardiman J
NCI Monogr; 1988; (6):235-9. PubMed ID: 2832762
[TBL] [Abstract][Full Text] [Related]
11. Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused by cis-diamminedichloroplatinum(II) or diammine-(1,1-cyclobutanedicarboxylato)platinum(II).
Gringeri A; Keng PC; Borch RF
Cancer Res; 1988 Oct; 48(20):5708-12. PubMed ID: 2844391
[TBL] [Abstract][Full Text] [Related]
12. Rationale for initial clinical trials and future development of radioprotectors.
Phillips TL
Cancer Clin Trials; 1980; 3(2):165-73. PubMed ID: 6253097
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
Milas L; Hunter N; Reid BO; Thames HD
Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
[TBL] [Abstract][Full Text] [Related]
15. Radioprotective effect of WR-2721 on haematopoiesis in mice. II. Morphological changes of bone marrow and spleen.
Macková N; Brezáni P
Radiobiol Radiother (Berl); 1988; 29(5):595-601. PubMed ID: 2852383
[No Abstract] [Full Text] [Related]
16. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
Rasey JS; Krohn KA; Magee S; Nelson N; Chin L
Radiat Res; 1986 Nov; 108(2):167-75. PubMed ID: 3024202
[TBL] [Abstract][Full Text] [Related]
18. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
Esposito M; Viale M; Vannozzi MO; Zicca A; Cadoni A; Merlo F; Gogioso L
Toxicol Appl Pharmacol; 1996 Oct; 140(2):370-7. PubMed ID: 8887454
[TBL] [Abstract][Full Text] [Related]
19. Radioprotection of pronormoblasts and normoblasts by WR-2721.
Naruka K; Bhartiya HC
Strahlenther Onkol; 1990 Aug; 166(8):542-4. PubMed ID: 2168582
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]